成人做爰免费视频免费看_成人a级高清视频在线观看,成人a大片在线观看,成人a大片高清在线观看,成人av在线播放,一a一级片,一级黄 中国色 片,一级黄 色蝶 片,一级黄色 片生活片

作者： Jinli Wang^ab，Christine J.Lee^a，Michael B.Deci^a，Natalie Jasiewicz^e，Anjali Verma^e，John MCanty^cd，Juliane Nguyen^e

^a Department of Pharmaceutical Sciences, School of Pharmacy, University at Buffalo, The State University of New York, Buffalo, NY, USA

^b Department of Biomedical Engineering, University at Buffalo, The State University of New York, Buffalo, NY, USA

^c Department of Medicine, Department of Physiology and Biophysics, Department of Biomedical Engineering, The Clinical and Translational Research Center of the University at Buffalo, Buffalo, NY, USA

^d VA Western New York Healthcare System, Buffalo, NY, USA

^e Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

摘要：Myocardial infarction (MI) remains a major cause of mortality worldwide. Despite significant advances in MI treatment, many who survive the acute event are at high risk of chronic cardiac morbidity. Here we developed a cell-free therapeutic that capitalizes on the antifibrotic effects of micro(mi)RNA-101a and exploits the multi-faceted regenerative activity of mesenchymal stem cell (MSC) extracellular nanovesicles (eNVs). While the majority of MSC eNVs require local delivery via intramyocardial injection to exert therapeutic efficacy, we have developed MSC eNVs that can be administered in a minimally invasive manner, all while remaining therapeutically active. When loaded with miR-101a, MSC eNVs substantially decreased infarct size (9.2?±?1.7% vs. 20.0?±?6.5%) and increased ejection fraction (53.6?±?7.6% vs. 40.3?±?6.0%) and fractional shortening (23.6?±?4.3% vs. 16.6?±?3.0%) compared to control. These findings are significant as they represent an advance in the development of minimally invasive cardio-therapies.